Golden State Equity Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,541
Closed -$4.76M 405
2026
Q1
$4.76M Buy
13,541
+8,192
+153% +$2.92M 0.36% 51
2025
Q4
$1.75M Buy
5,349
+50
+0.9% +$15.9K 0.28% 71
2025
Q3
$1.5M Sell
5,299
-571
-10% -$166K 0.25% 90
2025
Q2
$1.64M Buy
5,870
+661
+13% +$187K 0.3% 74
2025
Q1
$1.62M Buy
5,209
+54
+1% +$15.9K 0.32% 76
2024
Q4
$1.34M Buy
5,155
+4,981
+2,863% +$1.48M 0.26% 89
2024
Q3
$56.1K Sell
174
-5,198
-97% -$1.7M 0.03% 363
2024
Q2
$1.68M Buy
+5,372
New +$1.58M 0.35% 64
2023
Q4
$2.22M Sell
7,694
-964
-11% -$263K 0.54% 42
2023
Q3
$2.33M Buy
8,658
+2,904
+50% +$725K 0.65% 37
2023
Q2
$1.28M Buy
5,754
+1,135
+25% +$263K 0.36% 67
2023
Q1
$1.12M Buy
+4,619
New +$1.13M 0.6% 51
2022
Q1
$1.19M Buy
4,938
+2,712
+122% +$623K 0.6% 48
2021
Q4
$501K Sell
2,226
-1,357
-38% -$286K 0.25% 95
2021
Q3
$762K Sell
3,583
-71
-2% -$16.3K 0.31% 80
2021
Q2
$891K Buy
3,654
+417
+13% +$103K 0.34% 74
2021
Q1
$805K Buy
3,237
+1,073
+50% +$256K 0.46% 63
2020
Q4
$497K Buy
+2,164
New +$499K 0.34% 83

Other funds holding AMGN

Golden State Equity Partners's AMGN Position: Q2 2026 in Review

Golden State Equity Partners sold out of Amgen (AMGN) in Q2 2026, closing a stake of 13,541 shares — an estimated $4.76M sold.

Golden State Equity Partners first reported a position in AMGN in Q4 2020 and held it in 18 quarters. The position peaked at $4.76M in Q1 2026. 1,764 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Golden State Equity Partners reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 13,541 Amgen shares in Q2 2026, an estimated $4.76M.
  • Golden State Equity Partners first reported a position in Amgen in Q4 2020 and held it in 18 quarters.
  • Golden State Equity Partners's Amgen position peaked at $4.76M in Q1 2026.
  • 1,764 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.